Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SCG-101 by SCG Cell Therapy for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
SCG-101 is under clinical development by SCG Cell Therapy and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According...
Data Insights
SCG-101 by SCG Cell Therapy for Hepatocellular Carcinoma: Likelihood of Approval
SCG-101 is under clinical development by SCG Cell Therapy and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData,...